BBTX

15.9002.75%

Bambusa Therapeutics climbs 9%

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Bambusa Therapeutics (BBTX.US) climbed nearly 9% during regular trading to $17.42.

The Nasdaq Composite is down 4.52% over the past five sessions.

Bambusa Therapeutics previously completed an oversubscribed initial public offering priced at $16 per share, raising $169 million and reaching a fully diluted market cap of $856 million.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.